Pituitary Apoplexy: Comorbidities, Management, and Outcomes-A Spanish Observational Multicenter Study


Por: Biagetti B, Cordero Asanza E, Pérez-López C, Araujo-Castro M, Camara R, Guerrero-Pérez F, Vicente A, Lamas C, Serra G, Echarri AI, Ollero MD, González Molero I, Villar-Taibo R, Moure Rodríguez MD, García-Feijoo P, Berrocal VR, Sánchez Ramirez MN, Gutiéerrez Hurtado A, Capristan-Díaz V, Simó-Servat A, Gallach M, Safont Perez E, González Rosa V, Civantos S, Asensio-Wandosell D, Martinez-Saez E, Menéndez Torre E, Aulinas A, Iglesias P, Diez JJ, Bernabéu I, Álvarez-Escolá C and Puig-Domingo M

Publicada: 1 jun 2025 Ahead of Print: 1 oct 2024
Resumen:
Background: Pituitary apoplexy (PA) is the paradigm of endocrine and neurosurgical emergency. Objective: To evaluate the comorbidities, risk factors, clinical presentation, pituitary apoplexy score (PAS), and the outcomes of surgical vs conservative management of PA in Spain. Methods: Spanish multicenter, observational study of 301 patients with acute PA. Statistical analyses compared risk factors, clinical presentation, and outcomes between surgical and conservative treatment groups, adjusting for potential confounders. The prevalence of cardiovascular risk factors in patients with PA was compared with the Spanish population and with patients with nonfunctioning pituitary adenomas. Results: Median age was 59.3 years, 201 (66.8%) were men; nonfunctioning adenomas (77.9%) were the most common tumor type. The prevalence of diabetes (20.3% vs 13.9%, P < .01), hypertension (48.8% vs 33.4%, P < .01), and dyslipidemia (44.2% vs 23.3%, P < .01), exceeded the Spanish age-adjusted population prevalence. Overall, 209 (69.4%) underwent surgery and 92 (30.6%) received conservative treatment. Surgical patients had larger tumors (26.2 vs 21.0 mm, P < .01), more frequent chiasmal compression (77.2% vs 53.4%, P < .01), and higher values of PAS. In the follow-up, although there were no statistically significant differences in anterior pituitary hormonal deficits between treatments, permanent vasopressin deficiency was more frequent after surgery (14.8% vs 3.3%, P < .01). Conclusions: There is a high burden of cardiovascular risk factors among patients with PA, suggesting that metabolic factors may play a potential role in the development of PA. This underscores the need for comprehensive management of these conditions in addition to treating the apoplexy itself in this population. Surgical management has a relevant place in PA approach mainly in patients with higher PAS. However, it leads a permanent vasopressin deficit more frequently than a conservative approach.

Filiaciones:
Biagetti B:
 Endocrinology & Nutrition Department, Hospital Universitario Vall de Hebrón, CIBERER U747 (ISCIII), ENDO-ERN, Universitat Autónoma de Bracelona, Barcelona, PC 08032, Spain

Cordero Asanza E:
 Neurosurgery Department, Hospital Universitario Vall de Hebrón, Departament de Cirurgia i Ciències Morfològiques, Universitat Autónoma de Barcelona, PC 08032, Spain

Pérez-López C:
 Department of Neurosurgery, Hospital Universitario La Paz, Madrid, PC  28046, Spain

Araujo-Castro M:
 Department of Endocrinology and Nutrition, Hospital Universitario Ramón y Cajal, Madrid, PC 28034, Spain

Camara R:
 Endocrinology & Nutrition Service, La Fe University Hospital, Valencia, PC 46026, Spain

Guerrero-Pérez F:
 Department of Endocrinology, Hospital Universitari de Bellvitge, L'Hospitalet de Llobregat, Barcelona, PC 08907, Spain

Vicente A:
 Endocrinology & Nutrition Department, Hospital Universitario de Toledo, PC 45007, Toledo, Spain

Lamas C:
 Endocrinology & Nutrition Department, Hospital Universitario De Albacete, PC 02006, Albacete, Spain

Serra G:
 Department of Endocrinology, Son Espases University Hospital, Palma de Mallorca, PC 07120, Spain

Echarri AI:
 Department of Endocrinology, University Hospital of Navarre, Pamplona, PC 31008, Spain

Ollero MD:
 Department of Endocrinology, University Hospital of Navarre, Pamplona, PC 31008, Spain

González Molero I:
 Endocrinology & Nutrition Department, Hospital Regional Universitario de Málaga, IBIMA Plataforma BIONAND Málaga, PC 29010, Spain

Villar-Taibo R:
 Endocrinology & Nutrition Department, Hospital Universitario de Santiago de Compostela, A Coruña, PC 15706, Spain

Moure Rodríguez MD:
 Endocrinology & Nutrition Department, Hospital Universitario de Cruces, Bilbao, CP 48903, Spain

García-Feijoo P:
 Department of Neurosurgery, Hospital Universitario La Paz, Madrid, PC  28046, Spain

Berrocal VR:
 Department of Neurosurgery, Hospital Universitario Ramón y Cajal, Madrid, PC 28034, Spain

Sánchez Ramirez MN:
 Department of Endocrinology and Nutrition, Hospital Universitario Ramón y Cajal, Madrid, PC 28034, Spain

Gutiéerrez Hurtado A:
 Endocrinology & Nutrition Department, Hospital Universitario Central de Asturias, Instituto de Investigación del Principado de Asturias (ISPA), Asturias, PC 33011, Spain

Capristan-Díaz V:
 Department of Endocrinology, Hospital Universitario Puerta de Hierro Majadahonda, Instituto de Investigación Sanitaria Puerta de Hierro Segovia de Arana, Majadahonda, PC 28220, Spain

Simó-Servat A:
 Department of Endocrinology and Nutrition, Mutua de Terrassa University Hospital, Terrassa, PC 08221, Spain

Gallach M:
 Endocrinology & Nutrition Department, Hospital Universitario De Albacete, PC 02006, Albacete, Spain

Safont Perez E:
 Endocrinology & Nutrition Department, Hospital de la Santa Creu i Sant Pau, IR-SANTPAU, CIBERER-U747 (ISCIII), ENDO-ERN, Barcelona, PC 08025, Spain

González Rosa V:
 Endocrinology & Nutrition Department, Hospital Universitario Insular de Gran Canaria, Las Palmas, PC 35016, Spain

Civantos S:
 Endocrinology & Nutrition Department, Hospital Universitario Fuenlabrada, Madrid, PC 28942, Spain

Asensio-Wandosell D:
 Endocrinology & Nutrition Service, Germans Trias Hospital and Research Institute, Badalona, Centro de Investigación Biomédica en Red de Enfermedades Raras U747, Autonomous University of Barcelona, Barcelona, PC 8916, Spain

Martinez-Saez E:
 Pathology Department, Hospital Universitario Vall de Hebrón, Universitat Autónoma de Barcelona, Barcelona, PC 08032, Spain

Menéndez Torre E:
 Endocrinology & Nutrition Department, Hospital Universitario Central de Asturias, Instituto de Investigación del Principado de Asturias (ISPA), Asturias, PC 33011, Spain

Aulinas A:
 Department of Endocrinology and Nutrition, Mutua de Terrassa University Hospital, Terrassa, PC 08221, Spain

Iglesias P:
 Department of Endocrinology, Hospital Universitario Puerta de Hierro Majadahonda, Instituto de Investigación Sanitaria Puerta de Hierro Segovia de Arana, Majadahonda, PC 28220, Spain

 Department of Medicine, Universidad Autónoma de Madrid, Madrid, PC 28049, Spain

Diez JJ:
 Department of Endocrinology, Hospital Universitario Puerta de Hierro Majadahonda, Instituto de Investigación Sanitaria Puerta de Hierro Segovia de Arana, Majadahonda, PC 28220, Spain

 Department of Medicine, Universidad Autónoma de Madrid, Madrid, PC 28049, Spain

Bernabéu I:
 Endocrinology & Nutrition Department, Hospital Universitario de Santiago de Compostela, A Coruña, PC 15706, Spain

Álvarez-Escolá C:
 Endocrinology Department, Hospital Universitario La Paz, Madrid, PC 28046, Spain

:
 Endocrinology & Nutrition Service, Germans Trias Hospital and Research Institute, Badalona, Centro de Investigación Biomédica en Red de Enfermedades Raras U747, Autonomous University of Barcelona, Barcelona, PC 8916, Spain
ISSN: 0021972X





JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
Editorial
Oxford University Press, 2055 L ST NW, SUITE 600, WASHINGTON, DC 20036 USA, Estados Unidos America
Tipo de documento: Article
Volumen: 110 Número: 6
Páginas: 1811-1820
WOS Id: 001337025800001
ID de PubMed: 39298667

MÉTRICAS